A citation-based method for searching scientific literature

Alastair Compston, Alasdair Coles. Lancet 2008
Times Cited: 3209







List of co-cited articles
320 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman,[...]. Lancet Neurol 2018
16

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Chris H Polman, Stephen C Reingold, Brenda Banwell, Michel Clanet, Jeffrey A Cohen, Massimo Filippi, Kazuo Fujihara, Eva Havrdova, Michael Hutchinson, Ludwig Kappos,[...]. Ann Neurol 2011
12


Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.
Clare Walton, Rachel King, Lindsay Rechtman, Wendy Kaye, Emmanuelle Leray, Ruth Ann Marrie, Neil Robertson, Nicholas La Rocca, Bernard Uitdehaag, Ingrid van der Mei,[...]. Mult Scler 2020
350
8

Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
W I McDonald, A Compston, G Edan, D Goodkin, H P Hartung, F D Lublin, H F McFarland, D W Paty, C H Polman, S C Reingold,[...]. Ann Neurol 2001
7

Immunopathology of multiple sclerosis.
Calliope A Dendrou, Lars Fugger, Manuel A Friese. Nat Rev Immunol 2015
6

The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Josa M Frischer, Stephan Bramow, Assunta Dal-Bianco, Claudia F Lucchinetti, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Hans Lassmann. Brain 2009
937
6


Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Stephen Sawcer, Garrett Hellenthal, Matti Pirinen, Chris C A Spencer, Nikolaos A Patsopoulos, Loukas Moutsianas, Alexander Dilthey, Zhan Su, Colin Freeman, Sarah E Hunt,[...]. Nature 2011
5

The changing demographic pattern of multiple sclerosis epidemiology.
Nils Koch-Henriksen, Per Soelberg Sørensen. Lancet Neurol 2010
704
5

Multiple Sclerosis.
Daniel S Reich, Claudia F Lucchinetti, Peter A Calabresi. N Engl J Med 2018
5

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Ashley H Beecham, Nikolaos A Patsopoulos, Dionysia K Xifara, Mary F Davis, Anu Kemppinen, Chris Cotsapas, Tejas S Shah, Chris Spencer, David Booth, An Goris,[...]. Nat Genet 2013
902
5

Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Jorge Correale, María I Gaitán, María C Ysrraelit, Marcela P Fiol. Brain 2017
273
4

Defining the clinical course of multiple sclerosis: the 2013 revisions.
Fred D Lublin, Stephen C Reingold, Jeffrey A Cohen, Gary R Cutter, Per Soelberg Sørensen, Alan J Thompson, Jerry S Wolinsky, Laura J Balcer, Brenda Banwell, Frederik Barkhof,[...]. Neurology 2014
4

Optic neuritis.
Ahmed T Toosy, Deborah F Mason, David H Miller. Lancet Neurol 2014
308
4

Treatment of Multiple Sclerosis: A Review.
Stephen L Hauser, Bruce A C Cree. Am J Med 2020
162
4

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Ludwig Kappos, Amit Bar-Or, Bruce A C Cree, Robert J Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L Arnold, Sophie Arnould, Tatiana Scherz,[...]. Lancet 2018
457
4

Multiple sclerosis.
Alan J Thompson, Sergio E Baranzini, Jeroen Geurts, Bernhard Hemmer, Olga Ciccarelli. Lancet 2018
831
4

Immunology of multiple sclerosis.
Mireia Sospedra, Roland Martin. Annu Rev Immunol 2005
4

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
Axel Petzold, Laura J Balcer, Peter A Calabresi, Fiona Costello, Teresa C Frohman, Elliot M Frohman, Elena H Martinez-Lapiscina, Ari J Green, Randy Kardon, Olivier Outteryck,[...]. Lancet Neurol 2017
276
4

Multiple sclerosis - a review.
R Dobson, G Giovannoni. Eur J Neurol 2019
495
4

A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis.
Ivana Nikić, Doron Merkler, Catherine Sorbara, Mary Brinkoetter, Mario Kreutzfeldt, Florence M Bareyre, Wolfgang Brück, Derron Bishop, Thomas Misgeld, Martin Kerschensteiner. Nat Med 2011
484
4

Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course.
Rosalind Kalb, Theodore R Brown, Susan Coote, Kathleen Costello, Ulrik Dalgas, Eric Garmon, Barbara Giesser, June Halper, Herb Karpatkin, Jennifer Keller,[...]. Mult Scler 2020
69
5


Multiple sclerosis: an immune or neurodegenerative disorder?
Bruce D Trapp, Klaus-Armin Nave. Annu Rev Neurosci 2008
4

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Chris H Polman, Paul W O'Connor, Eva Havrdova, Michael Hutchinson, Ludwig Kappos, David H Miller, J Theodore Phillips, Fred D Lublin, Gavin Giovannoni, Andrzej Wajgt,[...]. N Engl J Med 2006
3


Long-term evolution of multiple sclerosis disability in the treatment era.
Bruce A C Cree, Pierre-Antoine Gourraud, Jorge R Oksenberg, Carolyn Bevan, Elizabeth Crabtree-Hartman, Jeffrey M Gelfand, Douglas S Goodin, Jennifer Graves, Ari J Green, Ellen Mowry,[...]. Ann Neurol 2016
240
3

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
Anna He, Bernd Merkel, James William L Brown, Lana Zhovits Ryerson, Ilya Kister, Charles B Malpas, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Tim Spelman,[...]. Lancet Neurol 2020
116
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
3

Differential roles of microglia and monocytes in the inflamed central nervous system.
Ryo Yamasaki, Haiyan Lu, Oleg Butovsky, Nobuhiko Ohno, Anna M Rietsch, Ron Cialic, Pauline M Wu, Camille E Doykan, Jessica Lin, Anne C Cotleur,[...]. J Exp Med 2014
553
3

Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Bernhard Hemmer, Martin Kerschensteiner, Thomas Korn. Lancet Neurol 2015
325
3

Multiple sclerosis.
J H Noseworthy, C Lucchinetti, M Rodriguez, B G Weinshenker. N Engl J Med 2000
3

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Amit Bar-Or, Lama Fawaz, Boli Fan, Peter J Darlington, Aja Rieger, Christine Ghorayeb, Peter A Calabresi, Emmanuelle Waubant, Stephen L Hauser, Jiameng Zhang,[...]. Ann Neurol 2010
336
3

Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
Myla D Goldman, Ruth Ann Marrie, Jeffrey A Cohen. Mult Scler 2008
423
3

Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.
Ulrik Dalgas, Martin Langeskov-Christensen, Egon Stenager, Morten Riemenschneider, Lars G Hvid. Curr Neurol Neurosci Rep 2019
89
3

Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
Ilse Baert, Jennifer Freeman, Tori Smedal, Ulrik Dalgas, Anders Romberg, Alon Kalron, Helen Conyers, Iratxe Elorriaga, Benoit Gebara, Johanna Gumse,[...]. Neurorehabil Neural Repair 2014
140
3

Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
Tobias Zrzavy, Simon Hametner, Isabella Wimmer, Oleg Butovsky, Howard L Weiner, Hans Lassmann. Brain 2017
324
3

Multiple sclerosis.
Alastair Compston, Alasdair Coles. Lancet 2002
3

Overexpression of the Cytokine BAFF and Autoimmunity Risk.
Maristella Steri, Valeria Orrù, M Laura Idda, Maristella Pitzalis, Mauro Pala, Ilenia Zara, Carlo Sidore, Valeria Faà, Matteo Floris, Manila Deiana,[...]. N Engl J Med 2017
207
3

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Cris S Constantinescu, Nasr Farooqi, Kate O'Brien, Bruno Gran. Br J Pharmacol 2011
787
3

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Simon Faissner, Jason R Plemel, Ralf Gold, V Wee Yong. Nat Rev Drug Discov 2019
175
3

In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
In-Young Choi, Phil Lee, Peter Adany, Abbey J Hughes, Scott Belliston, Douglas R Denney, Sharon G Lynch. Mult Scler 2018
47
6



Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation.
Marta Joana Costa Jordão, Roman Sankowski, Stefanie M Brendecke, Sagar, Giuseppe Locatelli, Yi-Heng Tai, Tuan Leng Tay, Eva Schramm, Stephan Armbruster, Nora Hagemeyer,[...]. Science 2019
377
3

Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes.
Timothy R Hammond, Connor Dufort, Lasse Dissing-Olesen, Stefanie Giera, Adam Young, Alec Wysoker, Alec J Walker, Frederick Gergits, Michael Segel, James Nemesh,[...]. Immunity 2019
776
3

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Paul Browne, Dhia Chandraratna, Ceri Angood, Helen Tremlett, Chris Baker, Bruce V Taylor, Alan J Thompson. Neurology 2014
633
3

Progression of regional grey matter atrophy in multiple sclerosis.
Arman Eshaghi, Razvan V Marinescu, Alexandra L Young, Nicholas C Firth, Ferran Prados, M Jorge Cardoso, Carmen Tur, Floriana De Angelis, Niamh Cawley, Wallace J Brownlee,[...]. Brain 2018
163
3

Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis.
Simon Thebault, Mohammad Abdoli, Seyed-Mohammad Fereshtehnejad, Daniel Tessier, Vincent Tabard-Cossa, Mark S Freedman. Sci Rep 2020
55
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.